tiprankstipranks
Trending News
More News >
Orchestra BioMed Holdings (OBIO)
NASDAQ:OBIO
US Market

Orchestra BioMed Holdings (OBIO) Income Statement

Compare
99 Followers

Orchestra BioMed Holdings Income Statement

Last quarter (Q4 2025), Orchestra BioMed Holdings's total revenue was $30.92M, an increase of 3461.87% from the same quarter last year. In Q4, Orchestra BioMed Holdings's net income was $6.25M. See Orchestra BioMed Holdings’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Mar 25Dec 23Dec 22Dec 21
Total Revenue
$ 33.48M$ 2.64M$ 2.76M$ 3.53M$ -782.00K
Gross Profit
$ 33.29M$ 2.43M$ 2.57M$ 3.21M$ -981.00K
Operating Expenses
$ 85.10M$ 66.73M$ 54.08M$ 35.87M$ 20.82M
Depreciation and Amortization
$ 327.00K$ 308.00K$ 287.00K$ 222.00K$ 181.00K
EBITDA
$ -51.48M$ -63.99M$ -51.22M$ -32.44M$ -21.62M
Operating Income
$ -51.81M$ -64.30M$ -51.51M$ -32.66M$ -21.80M
Other Income/Expenses
$ -1.15M$ 3.28M$ 2.39M$ -951.00K$ -1.22M
Pretax Income
$ -52.95M$ -61.02M$ -49.12M$ -33.61M$ -23.01M
Net Income
$ -52.95M$ -61.02M$ -49.12M$ -33.61M$ -23.01M
Per Share Metrics
Basic EPS
$ -1.11$ -1.66$ -1.48$ -1.32$ -0.02
Diluted EPS
$ -1.11$ -1.66$ -1.48$ -1.32$ -0.02
Weighted Average Shares Outstanding
38.39B 36.82M 33.23M 25.47M 20.45M
Weighted Average Shares Outstanding (Diluted)
38.39B 36.82M 33.23M 25.47M 20.45M
Currency in USD

Orchestra BioMed Holdings Earnings and Revenue History